
|Articles|July 7, 2011
google plus one (home page)
Advertisement
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Fremanezumab-vfrm (Ajovy) reduces migraine frequency in children, adolescents with episodic migraine
2
Matt Thomas, MD, discusses pertussis trends, early recognition, and risks for infants
3
HFNC use in bronchiolitis linked to higher childhood asthma risk
4
Andrew Hershey, MD, discusses latest phase 3 results of fremanezumab-vfrm for pediatric episodic migraine
5








